Shopping Cart
- Remove All
Your shopping cart is currently empty
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which promotes proliferation of human Mpl (hMpl) expression and mouse pro B cell line Ba/F3. The phosphorylation of JAK2, STAT3, STAT5 and MAPK is induced. Butyzamide has been shown to help increase platelet levels in mouse xenotransplantation trials.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $285 | In Stock | |
| 5 mg | $687 | In Stock | |
| 10 mg | $998 | In Stock | |
| 25 mg | $1,480 | In Stock | |
| 50 mg | $1,990 | In Stock | |
| 100 mg | $2,690 | In Stock |
| Description | Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which promotes proliferation of human Mpl (hMpl) expression and mouse pro B cell line Ba/F3. The phosphorylation of JAK2, STAT3, STAT5 and MAPK is induced. Butyzamide has been shown to help increase platelet levels in mouse xenotransplantation trials. |
| In vitro | Butyzamide (3 μM; 15 minutes) induces phosphorylation of JAK2, STAT3, STAT5, and MAPK in Ba/F3-hMpl cells.[1] Butyzamide (3 μM; 48 hours) induces colony-forming unit-megakaryocyte (CFU-MK) and polyploid megakaryocyte formation in human CD34+ hematopoietic progenitor cells.[1] |
| In vivo | Butyzamide (10 mg/kg, 50 mg/kg; oral administration; once daily for 20 days) enhances human platelet levels in NOG mice transplanted with human fetal liver-derived CD34+ cells.[1] |
| Molecular Weight | 591.55 |
| Formula | C29H32Cl2N2O5S |
| Cas No. | 1110767-45-7 |
| Smiles | O(C)C1=C(C=CC=C1C(OCCC)C(C)(C)C)C=2N=C(NC(=O)C3=CC(Cl)=C(/C=C(/C(O)=O)\C)C(Cl)=C3)SC2 |
| Relative Density. | 1.299 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225.0 mg/mL (751.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.